After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active ...

Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of ...

This transcript has been edited for clarity. John Kane, MD: I am Dr John Kane. I am a professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New ...

GLP-1 medications may offer significant benefits, but for some people with a history of anorexia, weight loss itself can ...

Teclistamab (Tecvayli; Johnson & Johnson) appears poised to move into earlier lines of care as a monotherapy, as bispecific antibodies made big news in the treatment of blood cancers and disorders on ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

Relapse, or recurrence, occurs when multiple myeloma symptoms return, such as bone pain, fatigue, and kidney problems. It’s possible to live for many years after a relapse of multiple myeloma. Outlook ...

When my daughter relapsed after six years of sobriety, it took her less than five months to lose everything she had worked so hard for: her job, her savings, her good credit rating, and—most ...

A number of approaches have been used to treat patients with CML in relapse after transplantation depending on disease phase, presence of graft-versus-host disease (GvHD), performance status of the ...